Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142948 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142949 |
| CAS No | NA |
| Mol.F. | C19H27ClN4O5S |
| Mol.Wt. | 459 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142950 |
| CAS No | NA |
| Mol.F. | C19H26ClN5O6S |
| Mol.Wt. | 488 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142951 |
| CAS No | NA |
| Mol.F. | C16H20ClN5O2 |
| Mol.Wt. | 349.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142952 |
| CAS No | NA |
| Mol.F. | C16H21ClN4O2 |
| Mol.Wt. | 336.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142953 |
| CAS No | NA |
| Mol.F. | C8H10N4O5S2 |
| Mol.Wt. | 306.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142954 |
| CAS No | NA |
| Mol.F. | C7H5Cl2N5O6S2 |
| Mol.Wt. | 390.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142955 |
| CAS No | NA |
| Mol.F. | C7H6Cl2N4O5S2 |
| Mol.Wt. | 361.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142956 |
| CAS No | NA |
| Mol.F. | C15H15Cl2N7O9S4 |
| Mol.Wt. | 636.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142957 |
| CAS No | NA |
| Mol.F. | C7H5ClN4O5S2 |
| Mol.Wt. | 324.71 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142958 |
| CAS No | NA |
| Mol.F. | C6H4ClN5O5S2 |
| Mol.Wt. | 325.70 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142959 |
| CAS No | NA |
| Mol.F. | C7H6ClN3O3S |
| Mol.Wt. | 247.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142960 |
| CAS No | NA |
| Mol.F. | C12H16N2O3 |
| Mol.Wt. | 236.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142961 |
| CAS No | NA |
| Mol.F. | C14H20N2O6 |
| Mol.Wt. | 312.32 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142962 |
| CAS No | NA |
| Mol.F. | C27H37N3O7 |
| Mol.Wt. | 515.61 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142963 |
| CAS No | NA |
| Mol.F. | C14H18N2O5 |
| Mol.Wt. | 294.31 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |